Major depressive disorder: hypothesis, mechanism, prevention and treatment
Большое депрессивное расстройство: гипотезы, механизмы, профилактика и лечение
2024-02-08
SCID: 54.1/8vfbga6j
Discuss with AI
HPA axisantidepressant treatmentcytokine hypothesismajor depressive disorderneuroplasticity
Figures from the paper
Abstract (AI)
Worldwide, the incidence of major depressive disorder (MDD) is increasing annually, resulting in greater economic and social burdens. Moreover, the pathological mechanisms of MDD and the mechanisms underlying the effects of pharmacological treatments for MDD are complex and unclear, and additional diagnostic and therapeutic strategies for MDD still are needed. The currently widely accepted theories of MDD pathogenesis include the neurotransmitter and receptor hypothesis, hypothalamic-pituitary-adrenal (HPA) axis hypothesis, cytokine hypothesis, neuroplasticity hypothesis and systemic influence hypothesis, but these hypothesis cannot completely explain the pathological mechanism of MDD. Even it is still hard to adopt only one hypothesis to completely reveal the pathogenesis of MDD, thus in recent years, great progress has been made in elucidating the roles of multiple organ interactions in the pathogenesis MDD and identifying novel therapeutic approaches and multitarget modulatory strategies, further revealing the disease features of MDD. Furthermore, some newly discovered potential pharmacological targets and newly studied antidepressants have attracted widespread attention, some reagents have even been approved for clinical treatment and some novel therapeutic methods such as phototherapy and acupuncture have been discovered to have effective improvement for the depressive symptoms. In this work, we comprehensively summarize the latest research on the pathogenesis and diagnosis of MDD, preventive approaches and therapeutic medicines, as well as the related clinical trials.
Key Findings
1
Established MDD mechanisms—including neurotransmitter, HPA-axis, cytokine, neuroplasticity, and systemic hypotheses—cannot fully explain its pathogenesis individually.
2
Major depressive disorder incidence is increasing worldwide, creating growing economic and social burdens.
3
New pharmacological targets and antidepressants have emerged, with some agents receiving clinical approval.
4
Nonpharmacological approaches, including phototherapy and acupuncture, have shown improvement in depressive symptoms.
5
Recent research emphasizes interactions among multiple organs and supports multitarget modulatory strategies for understanding and treating MDD.
Research Object
major depressive disorder (MDD)
Research Subject
its pathogenesis, diagnosis, prevention, and treatment, including underlying mechanisms and therapeutic strategies
Publication Details
Publication Date
2024-02-08
Journal
Publisher
ISSN
Cited by
1069
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies2013
Introduction to Radiomics2020
Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies2018